Will Maple avoid deeper declines amid persistent seller pressure?

Will Maple avoid deeper declines amid persistent seller pressure?
Maple slides 7.56% to $0.088 today

Maple (SYRUP) is trading at $0.088, marking a daily decrease of 7.56%. The price is trading just above its key short-term averages but remains below intermediate and long-term averages, reflecting a recent slip in momentum.

SYRUP price prediction
24H -3.07%
$0.0853
48H 1.48%
$0.0893
7D -20%
$0.0704
1M -82.16%
$0.0157
3M -49.89%
$0.0441
6M -66.93%
$0.0291
12M 21.59%
$0.107
Current price: $0.088 -0.0015 1.68%
Real-time Data 17:01
Daily range 0.0835 Arrow from to Icon 0.0907
Weekly range 0.0881 Arrow from to Icon 0.1107
Loading...

Highlights

  • Maple Finance assets under management reached $4.73 billion as of November 20, representing a major increase in user capital flows.
  • Maple Institutional total value locked rose 15.5% to $870 million and syrupUSDG scaled to $375 million in its first quarter.
  • SYRUP/USD trades below key moving averages with strong sell momentum and is expected to consolidate between $0.0807 and $0.0931, with a 23% chance of a short-term upward move.

Institutional inflows and user growth as selling persists

Maple Finance’s assets under management reached $4.73 billion as of November 20, reflecting a significant increase in user capital flows, according to Tokenpost. This expansion has been accompanied by the syrupUSDG product quickly scaling to $375 million in its first quarter, showing rapid early adoption within Maple’s ecosystem. Additionally, Maple Institutional’s total value locked rose by 15.5% to $870 million, indicating growing institutional engagement. While these developments highlight positive activity within the Maple platform, price action has remained under broader selling pressure.

Maple Finance asset chart
Maple Finance price dynamics. Source: TradingView.

Bearish momentum sustained amid resistance and mixed signals

Technically, SYRUP/USD is trading just above the H1 SMA-20 at $0.088, but remains below the H1 SMA-50 at $0.0942 and the D1 SMA-200 at $0.18. The Ichimoku Kijun at $0.0915 acts as immediate resistance. MACD signals strong sell momentum, while ADX confirms selling pressure. RSI and CCI are both neutral, and Stoch RSI is in the overbought zone, hinting at a potential short-term pullback. Bull/Bear Power is slightly negative, suggesting sellers maintain an intraday advantage. Overall, most momentum indicators support the recent down move, but mixed signals from RSI, CCI, and Stoch RSI add a note of caution.

Downside favored amid volatility and resistance constraints

In the next trading day, SYRUP/USD is expected to fluctuate between $0.0807 and $0.0931, aligning with recent high volatility. There is a 23% probability of an upward move, making further declines more likely. Baseline expectations point to consolidation within the stated band. An upside scenario would require a break above resistance at $0.0915, while a breach of support near $0.0807 would open the way for additional bearish movement.

Anton Kharitonov, analyst at Traders Union, sees Maple’s significant AUM growth and institutional inflows as a strong indicator of fundamental platform health. However, technicals remain cautious with SYRUP/USD stuck below the H1 SMA-50 at $0.0942 and the D1 SMA-200 at $0.18, while momentum and price pressure dominate the short-term. Most indicators point to ongoing seller control despite a flurry of positive ecosystem news. "Until the price can retake key resistance levels, I remain defensive and see consolidation or further downside as the base case."

Earlier, analysts noted that Maple (SYRUP) remained under persistent bearish pressure despite improving platform fundamentals. The current article confirms this prevailing downside bias, with updated technicals suggesting traders should closely monitor the $0.0915 resistance and $0.0807 support for the next significant move.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.